All EHA CAR-T Abstracts
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
EHA
Comparison of four flow cytometry methods for CART-19 detection in B cell precursor acute lymphoblastic leukemia paediatric patients
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
Granulocyte colony stimulating factor (GCSF) administration does not affect prevalence and severity of CRS, ICANS nor outcome in patients with R/R large B cells lymphomas treated by CD19 CAR-T
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
Multi-technique follow-up of lymphoma patients undergoing commercial CAR-T cell therapy: experience from a single centre
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
TMTV correlates with early progression (EP) after CD19 CAR T-cell therapy in patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL)
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
BIANCA phase 2, single-arm, global trial to determine efficacy and safety of tisagenlecleucel in pediatric/young adult patients with relapsed/refractory B-cell non-hodgkin lymphoma
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
An assessment of the reimbursement landscape to CAR T-cell therapy in Europe
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
Tisagenlecleucel for pediatric/young adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia: preliminary report of b2001x focusing on prior exposure to blinatumomab and inotuzumab
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
Diclofenac in the management of cytokine release syndrome after CAR-T infusion in B-ALL pediatric patients
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]
Refractory hemophagocytic lymphohistiocytosis/macrophage-activation syndrome (hlh/mas) following treatment with tisagenlecleucel for refractory B-cell lymphoma
Log In with AHPRA Professional Number Login Some areas of the CAR-T Central site may only be accessed by health care professionals. You are required to enter your full AHPRA […]